Precision BioSciences Inc Allogeneic CAR T Update- Conference Call Transcript
Good day and thank you for standing by and welcome to the Allogeneic CAR T Update Conference Call. At this, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. (Operator Instructions).
I would now like to hand the conference over to Alex Kelly, Chief Financial Officer. Please, go ahead, sir.
Thank you very much and good morning everyone and welcome to our webcast to discuss the progress that we've made with our allogeneic CAR T programs.
Before we begin, I'd like to remind you that the statements that we make today on the webcast, they do not relate to matters of historical fact, our future expectations and our forward-looking statements. Our forward-looking statements are within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors, including without limitation the risk factors in Precision's
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |